On Friday, AVITA Medical Inc (NASDAQ: RCEL) opened lower -25.29% from the last session, before settling in for the closing price of $9.33. Price fluctuations for RCEL have ranged from $6.90 to $14.16 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 36.91%. Company’s average yearly earnings per share was noted 17.88% at the time writing. With a float of $24.65 million, this company’s outstanding shares have now reached $26.43 million.
Let’s determine the extent of company efficiency that accounts for 260 employees. In terms of profitability, gross margin is 85.85%, operating margin of -88.08%, and the pretax margin is -96.17%.
AVITA Medical Inc (RCEL) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of AVITA Medical Inc is 0.78%, while institutional ownership is 24.71%. The most recent insider transaction that took place on Mar 06 ’25, was worth 91,300. In this transaction Director of this company bought 11,000 shares at a rate of $8.30, taking the stock ownership to the 56,749 shares. Before that another transaction happened on Feb 20 ’25, when Company’s Director bought 10,000 for $10.09, making the entire transaction worth $100,900. This insider now owns 45,749 shares in total.
AVITA Medical Inc (RCEL) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 17.88% per share during the next fiscal year.
AVITA Medical Inc (NASDAQ: RCEL) Trading Performance Indicators
Check out the current performance indicators for AVITA Medical Inc (RCEL). In the past quarter, the stock posted a quick ratio of 1.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of AVITA Medical Inc (RCEL)
Looking closely at AVITA Medical Inc (NASDAQ: RCEL), its last 5-days average volume was 0.46 million, which is a jump from its year-to-date volume of 0.23 million. As of the previous 9 days, the stock’s Stochastic %D was 29.29%. Additionally, its Average True Range was 0.72.
During the past 100 days, AVITA Medical Inc’s (RCEL) raw stochastic average was set at 4.89%, which indicates a significant decrease from 10.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 125.29% in the past 14 days, which was higher than the 105.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.88, while its 200-day Moving Average is $10.11. However, in the short run, AVITA Medical Inc’s stock first resistance to watch stands at $7.55. Second resistance stands at $8.12. The third major resistance level sits at $8.60. If the price goes on to break the first support level at $6.50, it is likely to go to the next support level at $6.02. Now, if the price goes above the second support level, the third support stands at $5.45.
AVITA Medical Inc (NASDAQ: RCEL) Key Stats
There are currently 26,435K shares outstanding in the company with a market cap of 173.13 million. Presently, the company’s annual sales total 64,250 K according to its annual income of -61,850 K. Last quarter, the company’s sales amounted to 18,410 K and its income totaled -11,590 K.
